GGrantIndex
← Search

SUBTHRESHOLD OPIOID USE DISORDER PREVENTION TRIAL (CTN-0101). DSC5 CONTRACT. 09/20/2019 - 11/16/2020. N01DA-19-2250.

$245,168N01FY2022DANIH

The Emmes Company, Llc, Rockville MD

Investigators

Paul Vanveldhuisencontact

Abstract

SUBTHRESHOLD OPIOID USE DISORDER PREVENTION TRIAL (CTN-0101). This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative bolsters research across NIH to improve treatment for opioid misuse and addiction.

View original record on NIH RePORTER →